Belgian Health Care Knowledge Center has issued report on managed entry schemes in Belgium


May 2017

Belgian Health Care Knowledge Center has issued report on managed entry schemes in Belgium. Although the report excluded medical technologies from scope, it includes useful information about the concept of innovative payment schemes, taxonomy and provides an overview of international experience. 

The initial objective of this study was therefore to better understand the different types of managed entry agreements, to assess their impact and to provide recommendations on how to improve the process. The following research questions were raised:

  • What lessons can be learned from the European experience? Based on a review of the literature, the following subquestions KCE analyzed:
    • What is the potential impact of MEAs? What are their main strenghts and weaknesses?
    • Which challenges needed to be overcome and what are the potential solutions?
  • What lessons can be learned from the Belgian experience? Based on an evaluation of Belgian conventions, the following subquestions KCE analyzed:
    • Which kind of conventions were concluded in Belgium up to now and what are the possible practical problems with each type of convention in the Belgian context?
    • Which uncertainties and/or problems were adressed, how were they adressed and to what extent were these uncertainties and/or problems resolved?
    • Which conditions were imposed in the conventions and to what extent were these conditions respected? What were the results of the conventions already expired? Were the initial objectives met? What was the impact of these conventions on the reimbursement negotiation process that followed them?

Full report in English language is available here.

Subscribe to our biweekly newsletter not to miss important reimbursement information.

Related news


Jun 2019

A syndicated report (>80 pages) includes the overview and statistics of 16 key innovation funding and coverage with evidence development schemes in seven European countries: Austria, Belgium, England, France, Germany, the Netherlands and Switzerland. The price of the report is €2900.

Read more


Jun 2019

On the 24th of April 2019, the French Technical Agency for Hospital Information (ATIH) has released a technical note in connection with the 2019 DRG changes. Several key updates in relation to the financing of hospitalization benefits as a change of DRGs for fractional flow reserve, package to finance the rehabilitation and infusion costs of the pulmonary system and implementation of two innovative packages for PULSANTE and WISE CRT devices were outlined.

Read more


Apr 2019

On the 14th of March of 2019, the Dutch National Health Care Institute has opened a project submission period in a framework of subsidy scheme called “Promising care.” This scheme makes it possible to obtain temporary financing for a maximum of 6 years for those treatment methods that look promising but are not yet reimbursed from the basic package. The period for submitting project ideas for promising care is from March 14 to May 14, 2019.

Read more


Feb 2019

Promising care must find its way to patients more quickly through inclusion in the basic health insurance. That is why the Dutch Ministry of Health, Welfare and Sport has adjusted the promising care with the new subsidy scheme. Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) carries out the scheme in collaboration with the Dutch Organization for Health Research and Development (Nederlandse organisatie voor gezondheidsonderzoek en zorginnovatie, ZonMw). The scheme will replace existing procedure with conditional reimbursement of medical technologies.

Read more


Jul 2018

Payment-for-performance schemes in health care remain controversial as there is no solid evidence that they improve quality of care. A new study, published in Health Policy by Herbst et al, did not show any positive long-term effects of the implementation of P4P on quality of care. The program was implemented within the integrated contract framework between one ophthalmological clinic and one statutory health insurance company in Germany.

Read more


Jun 2018

European Med Tech and IVD Reimbursement Consulting Ltd. released a report, which identifies and provides an overview of the innovative payment schemes for medical devices and in-vitro diagnostic tests in European countries. The report was supported by the grant from the Med Tech Europe. Access the full version of the report at our web-site.

Read more